Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 2
2012 1
2013 1
2014 4
2015 3
2016 8
2017 1
2018 7
2019 7
2020 8
2021 14
2022 6
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors.
Spampinato S, Rancati T, Waskiewicz JM, Avuzzi B, Garibaldi E, Faiella A, Villa E, Magli A, Cante D, Girelli G, Gatti M, Noris Chiorda B, Rago L, Ferrari P, Piva C, Pavarini M, Valdagni R, Vavassori V, Munoz F, Sanguineti G, Di Muzio N, Kirchheiner K, Fiorino C, Cozzarini C. Spampinato S, et al. Among authors: kirchheiner k. Acta Oncol. 2023 Nov;62(11):1440-1450. doi: 10.1080/0284186X.2023.2259597. Epub 2023 Nov 7. Acta Oncol. 2023. PMID: 37801288
In Reply to Murakami et al.
Vittrup AS, Spampinato S, Jensen NBK, Tanderup K, Kirchheiner K, Pötter R, Nout R, Jürgenliemk-Schulz IM. Vittrup AS, et al. Among authors: kirchheiner k. Int J Radiat Oncol Biol Phys. 2023 Jul 15;116(4):964-965. doi: 10.1016/j.ijrobp.2023.03.070. Int J Radiat Oncol Biol Phys. 2023. PMID: 37355314 No abstract available.
EviGUIDE - a tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer.
Ecker S, Kirisits C, Schmid M, Knoth J, Heilemann G, De Leeuw A, Sturdza A, Kirchheiner K, Jensen N, Nout R, Jürgenliemk-Schulz I, Pötter R, Spampinato S, Tanderup K, Eder-Nesvacil N. Ecker S, et al. Among authors: kirchheiner k. Radiother Oncol. 2023 Sep;186:109748. doi: 10.1016/j.radonc.2023.109748. Epub 2023 Jun 16. Radiother Oncol. 2023. PMID: 37330055 Free article.
Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer.
Ecker S, Kirisits C, Schmid M, De Leeuw A, Seppenwoolde Y, Knoth J, Trnkova P, Heilemann G, Sturdza A, Kirchheiner K, Spampinato S, Serban M, Jürgenliemk-Schulz I, Chopra S, Nout R, Tanderup K, Pötter R, Eder-Nesvacil N. Ecker S, et al. Among authors: kirchheiner k. Radiother Oncol. 2023 May;182:109524. doi: 10.1016/j.radonc.2023.109524. Epub 2023 Feb 9. Radiother Oncol. 2023. PMID: 36764459 Free article.
Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors.
Spampinato S, Tanderup K, Lindegaard JC, Schmid MP, Sturdza A, Segedin B, Jürgenliemk-Schulz IM, De Leeuw A, Bruheim K, Mahantshetty U, Chargari C, Rai B, Cooper R, van der Steen-Banasik E, Sundset M, Wiebe E, Villafranca E, Van Limbergen E, Pieters BR, Tee Tan L, Lutgens LCHW, Hoskin P, Smet S, Pötter R, Nout R, Chopra S, Kirchheiner K; EMBRACE Collaborative Group Appendix. Spampinato S, et al. Among authors: kirchheiner k. Radiother Oncol. 2023 Apr;181:109501. doi: 10.1016/j.radonc.2023.109501. Epub 2023 Jan 30. Radiother Oncol. 2023. PMID: 36720348 Free article.
Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Vittrup AS, Kirchheiner K, Pötter R, Fokdal LU, Jensen NBK, Spampinato S, Haie-Meder C, Schmid MP, Sturdza AE, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Wiebe E, van der Steen-Banasik E, Cooper R, Van Limbergen E, Sundset M, Pieters BR, Kirisits C, Lindegaard JC, Jürgenliemk-Schulz IM, Nout R, Tanderup K; EMBRACE Collaborative Group. Vittrup AS, et al. Among authors: kirchheiner k. Int J Radiat Oncol Biol Phys. 2023 Jul 15;116(4):807-824. doi: 10.1016/j.ijrobp.2023.01.002. Epub 2023 Jan 12. Int J Radiat Oncol Biol Phys. 2023. PMID: 36641039 Free article.
Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT, Nout R, Nesvacil N, de Leeuw A, Pötter R, Kirisits C; EMBRACE Collaborative Group. Schmid MP, et al. Among authors: kirchheiner k. J Clin Oncol. 2023 Apr 1;41(10):1933-1942. doi: 10.1200/JCO.22.01096. Epub 2023 Jan 4. J Clin Oncol. 2023. PMID: 36599120
Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study.
Lindegaard JC, Petric P, Schmid MP, Nesvacil N, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Kirchheiner K, Spampinato S, Jürgenliemk-Schulz I, Tanderup K, Kirisits C, Pötter R. Lindegaard JC, et al. Among authors: kirchheiner k. Int J Radiat Oncol Biol Phys. 2022 Jun 1;113(2):379-389. doi: 10.1016/j.ijrobp.2022.02.005. Epub 2022 Feb 12. Int J Radiat Oncol Biol Phys. 2022. PMID: 35157992
58 results